Johnson & Johnson May Be Forced To License Stents Patents To Complete Major Acquisition
The European Commission ruled this week Johnson & Johnson may need to license Guidant Corp.'s patents, which are held up in litigation, before acquisition of Guidant will be granted final approval....To view the full article, register now.
Already a subscriber? Click here to view full article